Thromb Haemost 2015; 114(04): 864-865
DOI: 10.1160/TH15-02-0146
Letters to the Editor
Schattauer GmbH

Venous thrombotic burden and the risk of subsequent overt cancer

Paolo Prandoni
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Anthonie W. A. Lensing
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Martin H. Prins
3   Department of Clinical Epidemiology, University of Maastricht, the Netherlands
,
Sabina Villalta
2   Department of Medicine, University of Treviso, Italy
,
Susanna Negri
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Andrea Piccioli
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Franco Noventa
1   Department of Cardiovascular Sciences University of Padua, Italy
› Author Affiliations
Further Information

Publication History

Received: 16 February 2015

Accepted after major revision: 08 May 2015

Publication Date:
29 November 2017 (online)

 

 
  • References

  • 1 Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.
  • 2 Monreal M, Lensing AWA, Prins MH. et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2004; 2: 876-881.
  • 3 Piccioli A, Lensing AWA, Prins MH. et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism. J Thromb Hae-most 2004; 2: 884-889.
  • 4 Van Doormaal FF, Terpstra W, Van Der Griend R. et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted?. J Thromb Haemost 2011; 9: 79-84.
  • 5 Piccioli A, Bernardi E, Dalla Valle F. et al. The value of CT scanning for the detection of occult cancer in patients with unprovoked VTE. The D’Acquapendente study. Submitted.
  • 6 Di Nisio M, Otten HM, Piccioli A. et al. Decision analysis for cancer screening in idiopathic venous thromboembolism. J Thromb Haemost 2005; 3: 2391-2396.
  • 7 Bura A, Cailleux N, Bienvenu B. et al. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004; 2: 441-444.
  • 8 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-722.
  • 9 Trujillo-Santos J, Prandoni P, Rivron-Guillot K. et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008; 6: 251-255.
  • 10 Prandoni P, Lensing AWA, Prins MH. et al. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 2015; 41: 133-140.